Alzheimer's Assocation Research only
All of
  • Go to
  • Research Center
  • AAIC
  • Journal
  • Grants
  • TrialMatch
  • Press
  • Donate
  • Contact Us
Science and Progress
Clinical Trials
Funding and Collaboration
You can Help
Stay Current
Video and Resources

Text Size

Small text Medium text Large text

Research Grants 2007

To view an abstract, select an author from the vertical list on the left.

2007 Grant - Colton

The Role of Nitric Oxide in the Pathology of Alzheimer's Disease

Carol A. Colton, Ph.D.
Duke University Medical Center
Durham, North Carolina

2007 Investigator-Initiated Research Grant

Alzheimer's disease is characterized by two key pathological features: (1) the assembly of beta-amyloid protein fragments into toxic structures and (2) the chemical alteration of tau proteins, which form abnormal structures called neurofibrillary tangles. The link between these two key features is not well understood.

Studies with genetically altered mice have been an important resource for characterizing the biology of Alzheimer's disease. A significant challenge, however, is developing a mouse model that not only creates both beta-amyloid and tau pathologies but also reveals the relationship between these features and results in the Alzheimer-like loss of brain cells.

Carol A. Colton, Ph.D., and colleagues recently developed a mouse model that carries a mutated human gene that results in the overproduction of beta-amyloid. This model is also missing the mouse gene that is essential for the production of nitric oxide. Nitric oxide plays a role in maintaining an appropriate chemical balance during cellular events.

As expected these mice developed beta-amyloid aggregates in the brain, but they also developed the Alzheimer-like tau pathology and experienced cell loss. This finding suggests a protective role for nitric oxide and may indicate the mechanism by which beta-amyloid pathology may be linked to tau pathology.

In this study, the researchers will examine mouse brains and assess the memories of the mice at different ages — or at different stages of disease progression — in order to determine the sequence of pathological events. They will also assess the effect of nitric oxide "treatment" on disease progression. The outcome of this work may elucidate not only the role of nitric oxide but also the link between beta-amyloid and tau pathologies.

Alzheimer's Association International Conference | July 16-20, 2017, London, England

Abstract Submissions Now Open

The Scientific Program Committee is now accepting submissions for poster
presentations, oral presentations and featured research sessions.